Zeke Capital Advisors’s Eastman Chemical EMN Stock Holding History

Zeke Capital Advisors’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,582	Closed	-$343K	–	573
2018 Q3	$343K	Hold	3,582	–	–	0.03%	490
2018 Q2	$358K	Hold	3,582	–	–	0.03%	364
2018 Q1	$378K	Hold	3,582	–	–	0.03%	395
2017 Q4	$332K	Hold	3,582	–	–	0.03%	368
2017 Q3	$324K	Buy	+3,582	New	+$305K	0.04%	311

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Zeke Capital Advisors's EMN Position: Q4 2018 in Review

Zeke Capital Advisors sold out of Eastman Chemical (EMN) in Q4 2018, closing a stake of 3,582 shares — an estimated $343K sold.

Zeke Capital Advisors first reported a position in EMN in Q3 2017 and held it in 5 quarters. The position peaked at $378K in Q1 2018. 688 funds tracked by Wall St. Rank hold EMN as of Q4 2018.

Zeke Capital Advisors reported no remaining Eastman Chemical position as of Q4 2018 after selling out during the quarter.
Zeke Capital Advisors sold 3,582 Eastman Chemical shares in Q4 2018, an estimated $343K.
Zeke Capital Advisors first reported a position in Eastman Chemical in Q3 2017 and held it in 5 quarters.
Zeke Capital Advisors's Eastman Chemical position peaked at $378K in Q1 2018.
688 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2018.

Based on Zeke Capital Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.